Switch to
View more

Tatva Chintan Pharma Chem Ltd

TATVA
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,244 cr, stock is ranked 498
Moderate RiskStock is 2.23x as volatile as Nifty
2,366.002.10 (-0.09%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
MaterialsSpecialty Chemicals
SmallcapWith a market cap of ₹5,244 cr, stock is ranked 498
Moderate RiskStock is 2.23x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
54.70
PB RatioPB Ratio
31.60
Dividend YieldDiv. Yield
0.08%
Sector PESector PE
13.57
Sector PBSector PB
2.73
Sector Div YldSctr Div Yld
2.29%

Forecast & RatingsDetailed Forecast 

80%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Tatva Chintan Pharma Chem is engaged in the manufacturing business of chemical products.

Investor PresentationView older 

Jul 25, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022207.55264.62306.29442.5420.5437.7852.2695.87
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Increased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has increased by 2.80%

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnAug 17, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about Newspaper Advertisements | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about Newspaper Advertisements | Download

Communication to shareholders as per Reg 30 
Announced OnAug 9, 2022

Pursuant to the changes introduced by the Finance Act, 2020, Dividend Distribution Tax has been abolished with effect from 01 April 2020 and the Dividend Income is taxable in the hands of the Shareholders. In this regard, please find enclosed herewith an email communication which has been sent to all the shareholders having their email ID's registered with the Company / Registrar & Transfer Agent / Depositories explaining the process and documentation required for claiming tax exemption/withholding tax on dividend to the Shareholders at prescribed rates.The above information shall be made available on the website of the Company at www.tatvachintan.com.You are requested to take the same on your records. | Download

Pursuant to the changes introduced by the Finance Act, 2020, Dividend Distribution Tax has been abolished with effect from 01 April 2020 and the Dividend Income is taxable in the hands of the Shareholders. In this regard, please find enclosed herewith an email communication which has been sent to all the shareholders having their email ID's registered with the Company / Registrar & Transfer Agent / Depositories explaining the process and documentation required for claiming tax exemption/withholding tax on dividend to the Shareholders at prescribed rates.The above information shall be made available on the website of the Company at www.tatvachintan.com.You are requested to take the same on your records. | Download

Monitoring Agency Report 
Announced OnAug 6, 2022

Tatva Chintan Pharma Chem Limited has informed the Exchange about Monitoring Agency Report | Download

Tatva Chintan Pharma Chem Limited has informed the Exchange about Monitoring Agency Report | Download

See all events